These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6113444)

  • 21. The impact of donor selection in avoiding hepatitis virus transmission.
    Warson SI
    Scand J Haematol Suppl; 1984; 40():313-5. PubMed ID: 6433458
    [No Abstract]   [Full Text] [Related]  

  • 22. [Non-A, non-B hepatitis. Recent aspects].
    Maroto Vela MD
    An R Acad Nac Med (Madr); 1983; 100(4):555-86. PubMed ID: 6428254
    [No Abstract]   [Full Text] [Related]  

  • 23. Current status of posttransfusion hepatitis.
    Alter HJ; Holland PV; Purcell RH
    Pathobiol Annu; 1980; 10():135-56. PubMed ID: 6777742
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevention of post-transfusion non-A, non-B hepatitis].
    Habibi B; Smilovici W
    Rev Fr Transfus Immunohematol; 1988 Oct; 31(3):537-86. PubMed ID: 3144032
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of hepatitis C virus infection in haemophiliacs.
    Lancet; 1990 Jun; 335(8703):1473-4. PubMed ID: 1972253
    [No Abstract]   [Full Text] [Related]  

  • 26. Reducing the incidence of non-A,non-B post-transfusion hepatitis by testing donor blood for alanine aminotransferase: economic considerations.
    Hornbrook MC; Dodd RY; Jacobs P; Friedman LI; Sherman KE
    N Engl J Med; 1982 Nov; 307(21):1315-21. PubMed ID: 6813736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor screening and epidemiology.
    Dodd RY
    Prog Clin Biol Res; 1985; 182():389-405. PubMed ID: 2994108
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis C virus infection in blood donors: to screen or not to screen?
    Anand AC; Dhot PS; Ohri VC
    Natl Med J India; 1997; 10(6):304-5. PubMed ID: 9481109
    [No Abstract]   [Full Text] [Related]  

  • 29. Non-A, non-B hepatitis: new findings and prospects for prevention.
    Tabor E; Gerety RJ
    Transfusion; 1979; 19(6):669-74. PubMed ID: 118555
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatitis C seroconversion in a blood donor: the value of ALT determination].
    Pérez Vaquero MA; Vesga Carasa MA; Ibarra Fontán A
    Sangre (Barc); 1996 Feb; 41(1):74. PubMed ID: 8779045
    [No Abstract]   [Full Text] [Related]  

  • 31. [Post-transfusion non-A, non-B hepatitis: is a specific test in sight?].
    Kühnl P; Sibrowski W; Böhm BO
    Beitr Infusionsther; 1989; 24():60-8. PubMed ID: 2481550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoprophylaxis of non-B hepatitis (hepatitis A and non-A non-B hepatitis).
    Spector R
    J Iowa Med Soc; 1982 Mar; 72(3):112-3, 118. PubMed ID: 6802909
    [No Abstract]   [Full Text] [Related]  

  • 33. Testing of blood donations for non-A, non-B hepatitis.
    Lancet; 1987 Aug; 2(8553):270-1. PubMed ID: 2886732
    [No Abstract]   [Full Text] [Related]  

  • 34. [Route of transmission and prevention of non-A, non-B hepatitis].
    Iino S
    Nihon Rinsho; 1988 Dec; 46(12):2729-34. PubMed ID: 3149346
    [No Abstract]   [Full Text] [Related]  

  • 35. New blood test raises thorny issues.
    Kolata G
    Science; 1986 Jul; 233(4760):149-50. PubMed ID: 3088724
    [No Abstract]   [Full Text] [Related]  

  • 36. [Contribution to the task of reducing the incidence of post transfusion non-A, non-B hepatitis].
    Hernández Sánchez MC; Vila Enriquez P; Alvarez Hernández M
    Sangre (Barc); 1989 Jun; 34(3):248-9. PubMed ID: 2503897
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis C: a major public health problem.
    Smith JP
    J Adv Nurs; 1993 Mar; 18(3):503-6. PubMed ID: 8095506
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anti-HB-core antibodies as a surrogate marker in blood donors].
    Blejer JL; Saguier MC; Salamone HJ
    Sangre (Barc); 1999 Jun; 44(3):240-1. PubMed ID: 10481590
    [No Abstract]   [Full Text] [Related]  

  • 39. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
    Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
    Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should we be screening blood donors for hepatitis G virus? The case against screening.
    Wong PY; Coghlan PJ; Angus PW
    Med J Aust; 1998 Oct; 169(7):375-7. PubMed ID: 9803251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.